Yield10 Bioscience Announces First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. QGEN

Go back to Yield10 Bioscience Announces First Quarter 2021 Financial Results

Yield10 Bioscience, Inc. (YTEN) Misses Q1 EPS by 5c, Revenues Miss

May 11, 2021 4:41 PM EDT

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q1 EPS of ($0.60), $0.05 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $196 thousand versus the consensus estimate of $220 thousand.

"We remain solidly on track for progressing our technical and business plans to support a specialty products business based on our Camelina platform," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10 Bioscience. "During 2021, we will scale-up seed production of certain new Camelina varieties as well as evaluate our novel yield traits in multi-site field trials conducted in... More